Eribulin Mesylate Injection
Product Images NDC 71288-173

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eribulin Mesylate (NDC 71288-173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Erib Structure)

Chemical structure of eribulin mesylate, showing its complex molecular configuration with multiple rings, oxygen, hydrogen, and nitrogen atoms, including the mesylate group (CH3-SO3H).*

FDA Label Image

Figure 1 (Erib Fig1)

A Kaplan-Meier survival curve chart comparing the proportion of patients alive over time (up to 36 months) between two groups: Eribulin Mesylate (N=508) and Control (N=254). The chart shows a higher survival proportion for the Eribulin Mesylate group compared to the Control group, with the number of patients at risk reported below the x-axis at various time points.*

FDA Label Image

Figure 2 (Erib Fig2)

A Kaplan-Meier survival curve comparing survival probabilities over time between Eribulin Mesylate and Dacarbazine. The x-axis represents survival time in months, and the y-axis shows survival probability. The graph includes patient counts at risk below the x-axis for each treatment group at different time points.*

FDA Label Image

Principal Display Package (Eribulin Mesylate Injection 1 mg per 2 mL Vial Label)

Label for Eribulin Mesylate Injection 1 mg per 2 mL (0.5 mg per mL) by Meitheal Pharmaceuticals Inc. The label indicates the product is for intravenous use, contains a 2 mL single-dose vial, and includes usage and storage instructions, a barcode, and caution as a cytotoxic agent. The NDC number 71288-173-02 is displayed prominently.*

FDA Label Image

Principal Display Package (Eribulin Mesylate Injection 1 mg per 2 mL Carton)

Packaging label for ERIBULIN MESYLATE Injection, 1 mg per 2 mL (0.5 mg per mL) single-dose vial by Meitheal Pharmaceuticals Inc. The label features dosage and use instructions, storage conditions, and a caution indicating the product is a cytotoxic agent. The vial is intended for intravenous use and the label includes a barcode, manufacturing information, and safety warnings in a combination of purple, pink, and white color blocks.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.